Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10-Q - PUMA BIOTECHNOLOGY, INC. | v231290_10q.htm |
| EX-32.1 - EXHIBIT 32.1 - PUMA BIOTECHNOLOGY, INC. | v231290_ex32-1.htm |
| EX-31.1 - EXHIBIT 31.1 - PUMA BIOTECHNOLOGY, INC. | v231290_ex31-1.htm |
| EX-31.2 - EXHIBIT 31.2 - PUMA BIOTECHNOLOGY, INC. | v231290_ex31-2.htm |
| EXCEL - IDEA: XBRL DOCUMENT - PUMA BIOTECHNOLOGY, INC. | Financial_Report.xls |
Exhibit 32.2
Certification of Principal Financial Officer
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the Quarterly Report of Innovative Acquisitions Corp. (the "Company") on Form 10-Q for the period ended June 30, 2011 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Robert Johnson, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
/s/ Robert Johnson
|
||
|
Robert Johnson
|
||
|
Principal Financial Officer
|
||
|
August 15, 2011
|